Khouri Charles

53PUBLICATIONS
69CO-AUTHORS
Toxicology (incl. clinical toxicology)Cancer geneticsBehavioural epidemiologyPharmacogenomicsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Sep 22, 2026
Signal Detection of Adverse Events Associated with PCSK9 Inhibitors: A Nationwide Sequence Symmetry and Combined Worldwide Disproportionality Analysis.

|Sep 16, 2026
Effectiveness of GLP-1 receptor agonists to prevent obstructive sleep apnea in patients with type 2 diabetes: active comparator, new user cohort study.

|Jun 10, 2026
Fenfluramine-associated pulmonary hypertension: a study of adverse events reporting system FAERS.

|Mar 20, 2026
[Assessing the risk-benefit balance of medicines: Some lessons from Covid-19].

Jean-Luc Cracowski, Mathieu Molimard, Vincent Richard

|Feb 12, 2026
Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design.

Clément Jambon-Barbara, Samy Suissa, Sophie Dell'Aniello

|Jan 28, 2026
Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.

Victoria Toro, Manon Mougin, Coline Brossat

Pageof 9

Frequent Collaborators

12 joint publications

David Montani

9 joint publications

Roustit Matthieu

9 joint publications

Marc Humbert

7 joint publications

Marie-Camille Chaumais